B7-33

• Description :

  B7-33 is a single-chain relaxin mimetic. B7-33 is a selective relaxin receptor 1 (RXFP1) agonist. B7-33 binds to RXFP1 and preferentially activates thepERK pathway over cAMP in cells (with RXFP1 expression) . B7-33 is an anti-fibrotic agent. B7-33 has cardioprotective effects[1][2].

• UNSPSC :

  12352209

• Target :

  RXFP Receptor

• Type :

  Peptides

• Related Pathways :

  GPCR/G Protein

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology; Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/b7-33.html

• Purity :

  99.31

• Solubility :

  H2O : 20 mg/mL

• Smiles :

  C([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](C(C)C)N)=O)[C@H](CC)C)=O)CCCCN)=O)CC(C)C)=O)CO)=O)=O)CCCNC(=N)N)=O)CCC(O)=O)=O)CC(C)C)=O)C(C)C)=O)CCCNC(=N)N)=O)C)=O)CCC(N)=O)=O)[C@H](CC)C)=O)C)=O)[C@H](CC)C)=O)CO)=O)=O)CCSC)=O)CO)=O)[C@@H](C)O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(N)=O)=O)CO)=O)CCCNC(=N)N)=O)CCCCN)=O)CO)=O)C=1C=2C(NC1)=CC=CC2

• Molecular Formula :

  C131H229N41O36S

• Molecular Weight :

  2986.54

• References & Citations :

  [1]Alam F, et al. The single-chain relaxin mimetic, B7-33, maintains the cardioprotective effects of relaxin and more rapidly reduces left ventricular fibrosis compared to perindopril in an experimental model of cardiomyopathy. Biomed Pharmacother. 2023 Apr;160:114370.|[2]Hossain MA, et al. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1. Chem Sci. 2016 Jun 1;7 (6) :3805-3819.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [1818415-56-3]